Suppr超能文献

埃及非霍奇金淋巴瘤的病毒和非病毒危险因素:按组织学和免疫亚型划分的异质性

Viral and non-viral risk factors for non-Hodgkin's lymphoma in Egypt: heterogeneity by histological and immunological subtypes.

作者信息

Goldman Lenka, Ezzat Sameera, Mokhtar Nadia, Abdel-Hamid Amany, Fowler Nathan, Gouda Iman, Eissa Soheir Abdel Latif, Abdel-Hamid Mohamed, Loffredo Christopher A

机构信息

Lombardi Cancer Center, Georgetown University, 3800 Reservoir Rd, PO Box 571465, Washington, DC 20057-1465, USA.

出版信息

Cancer Causes Control. 2009 Aug;20(6):981-7. doi: 10.1007/s10552-009-9316-0. Epub 2009 Mar 5.

Abstract

OBJECTIVE

Non-Hodgkin's lymphomas (NHL) are etiologically heterogeneous malignancies. In Egypt, we previously reported an association of increased NHL risk with chronic hepatitis C virus (HCV) infection. Our present aim is to assess the association between HCV infection and histological subtypes of NHL.

METHODS

We conducted a case-control study at the National Cancer Institute of Cairo University. Cases with NHL (n = 486) were matched to controls (n = 786) who were orthopedic patients from the same referral regions. Participants provided a blood sample for HCV markers (anti-HCV, HCV RNA) and answered a questionnaire on possible risk factors. Case-control differences were assessed by odds ratios and 95% confidence intervals from logistic regression analysis.

RESULTS

Cases with diffuse large B cell lymphoma (n = 146), chronic lymphocytic leukemia (n = 58), marginal zone lymphoma (n = 24), follicular lymphoma (n = 23), and mantle cell lymphoma (n = 16) were recruited. HCV RNA prevalence was 27% in controls and 26%-48% in the NHL subgroups: it was associated (p < 0.001) with diffuse large B cell, marginal zone, and follicular lymphomas with odds ratios of 3.2, 4.4, and 3.3, respectively.

CONCLUSION

HCV is a risk factor for diffuse large B cell, marginal zone, and follicular lymphomas in Egypt.

摘要

目的

非霍奇金淋巴瘤(NHL)是病因学上异质性的恶性肿瘤。在埃及,我们之前报道过NHL风险增加与慢性丙型肝炎病毒(HCV)感染有关。我们目前的目的是评估HCV感染与NHL组织学亚型之间的关联。

方法

我们在开罗大学国家癌症研究所进行了一项病例对照研究。NHL病例(n = 486)与来自相同转诊地区的骨科患者作为对照(n = 786)进行匹配。参与者提供血液样本检测HCV标志物(抗-HCV、HCV RNA),并回答关于可能风险因素的问卷。通过逻辑回归分析的比值比和95%置信区间评估病例对照差异。

结果

招募了弥漫性大B细胞淋巴瘤病例(n = 146)、慢性淋巴细胞白血病病例(n = 58)、边缘区淋巴瘤病例(n = 24)、滤泡性淋巴瘤病例(n = 23)和套细胞淋巴瘤病例(n = 16)。对照组中HCV RNA流行率为27%,NHL各亚组中为26% - 48%:它与弥漫性大B细胞淋巴瘤、边缘区淋巴瘤和滤泡性淋巴瘤相关(p < 0.001),比值比分别为3.2、4.4和3.3。

结论

在埃及,HCV是弥漫性大B细胞淋巴瘤、边缘区淋巴瘤和滤泡性淋巴瘤的一个风险因素。

相似文献

4
Hepatitis C infection and risk of malignant lymphoma.丙型肝炎感染与恶性淋巴瘤风险
Int J Cancer. 2008 Apr 15;122(8):1885-90. doi: 10.1002/ijc.23416.
5
Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.丙型肝炎病毒相关B细胞非霍奇金淋巴瘤
World J Gastroenterol. 2016 Jul 21;22(27):6214-23. doi: 10.3748/wjg.v22.i27.6214.

引用本文的文献

2
Cancer mortality patterns in selected Northern and Southern African countries.部分北非和南非国家的癌症死亡率模式。
Eur J Cancer Prev. 2024 May 1;33(3):192-199. doi: 10.1097/CEJ.0000000000000852. Epub 2023 Nov 24.
5
Hepatitis C virus and non-Hodgkin's lymphomas: A minireview.丙型肝炎病毒与非霍奇金淋巴瘤:一篇综述
J Adv Res. 2017 Mar;8(2):131-137. doi: 10.1016/j.jare.2016.11.005. Epub 2016 Dec 12.

本文引用的文献

2
Hepatitis C infection and risk of malignant lymphoma.丙型肝炎感染与恶性淋巴瘤风险
Int J Cancer. 2008 Apr 15;122(8):1885-90. doi: 10.1002/ijc.23416.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验